Treatment of the hypertensive patient with microvascular angina

Current Opinion in Cardiology

Volumn 14, Issue 5, 1999, Pages 370-374

  Ventura, Hector ^a,b   Loyalka, Pranav ^a   Smart, Frank W ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARGININE; ATENOLOL; BENIDIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOXAZOSIN; ENALAPRIL; NITRATE; NITRIC OXIDE; THALLIUM 201;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYMPTOM; SYNDROME X; THORAX PAIN;

ADRENERGIC ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; GATED BLOOD-POOL IMAGING; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MICROVASCULAR ANGINA;

EID: 0032826173     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199909000-00003     Document Type: Review

References (27)

1. Arbogast R, Bourassa MG: Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms: comparison with patients having significant coronary artery disease. Am J Cardiol 1973, 32:257-263.
2. Cannon RO, Epstein SE: "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988, 61:1338-1343.
3. Kaski JC, Elliot PM: Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics. Am J Cardiol 1995, 76:35D-42D.
4. Gersh BJ, Braunwald E, Rutherford JD: Chronic coronary artery disease: other manifestations of coronary artery disease. In Heart Disease: A Textbook of Cardiovascular Medicine, edn 5. Edited by Braunwald E. Philadelphia: WB Saunders; 1997:1343-1344.
5. Borjesson M, Albertsson P, Dellborg M, Eliasson T, Pilhall M, Rolny P, Mannheimer C: Esophageal dysfunction in syndrome X. Am J Cardiol 1998, 82:1187-1191.
6. Potts SG, Bass CM: Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries. A long term follow-up study. Psychol Med 1995, 25:339-347.
7. Cannon RO, Watson RM, Rosing DR, Epstein SE: Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983, 1:1359-1373.
8. Geltman EM, Henes CG, Sennef MJ, Sobel BE, Bergman SR: Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 1990, 16:586-595.
9. Cannon RO, Bonow RO, Bacharach SL, Green MV, Rosing DR, Leon MB, et al.: Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation 1985, 71:218-226.
10. Opherk D, Schuler G, Wetterauer K, Manthey J, Schwarz F, Kubler W: Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome x"). Circulation 1989, 80:1610-1616.
11. Iriarte M, Caso R, Murga N, Faus JM, Sagastagoitia D, Molinero E, et al.: Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy. Am J Cardiol 1995, 75:335-339.
12. Nalbantgil I, Onder R, Altintig A, Nalbantgil S, Kiliccioglu B, Boydak B, Yilmaz H: Therapeutic benefits of cilazapril in patients with syndrome X. Cardiology 1998, 89:130-133.
13. Motz W, Strauer BE: Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996, 27:1031-1038.
14. Iriarte M, Caso R, Murga N, Boveda J, Saenz R, Lopez de Argumedo M, et al.: Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina. Am J Cardiol 1995, 75:850-852.
15. Virdis A, Ghiadoni L, Lucarini A, Di Legge V, Taddei S, Salvetti A: Presence of cardiovascular structural changes is essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. Am J Hypertens 1996, 9:361-369.
16. Fragasso G, Chierchia SL, Pizzetti G, Rossetti E, Carlino M, Gerosa S, et al.: Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade. Heart 1997, 77:32-39.
17. Botker HE, Sonne HS, Schmitz O, Nielsen TT: Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. Am J Cardiol 1998, 82:1352-1356.
18. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A: Effect of benidipine on microvascular remodeling and coronary flow reserve in two-kidney, one clip Goldblatt hypertension. J Hypertens 1997, 26:1285-1294.
19. Sutsch G, Oechslin E, Mayer I, Hess OM: Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol 1995, 52:135-143.
20. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
21. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991, 83:1771-1779.
22. Keely FW, Elmoselhi A, Leenen FHH: Enalapril suppresses normal collagen accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol 1992, 62:H1013-H1021.
23. Leonardo F, Fragasso G, Rosano GM, Pagnotta P, Chierchia SL: Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 1997, 80:789-790.
24. Rosen SD, Boyd H, Rhodes CG, Kaski JC, Camici PG: Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. Am J Cardiol 1996, 78:37-42.
25. Klahr S: The role of L-arginine in hypertension and nephrotoxicity. Curr Opin Nephrol Hypertens 1998, 7:547-550.
26. Matsuoka H, Nakata M, Kohno K, Nomura G, Toshima H, Imaizumi T: Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 1996, 27:14-18.
27. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A: Effects of L-arginine supplementation on endothelium-dependent coronary vasodilatation with angina pectoris and normal coronary arteriograms. Circulation 1997, 96:1047-1048.